Anastomotic Leaks: Where Do We Stand? 🤔
By Oded Zmora
🔹 Nitinol spring – no evidence
🔹 Reinforcement (Bioabsorbable membrane, glue) – ❌ No benefit
🔹 SealG (Alginate sealant) – 🔬 Pilot study ↓ leaks, needs larger data
📸 Perfusion Imaging:
🔹 Meta-analysis – ICG ↓ to 7.3%
🔍 CME in 2025: Key Insights Dr Hermann Kessler
🔹 Colon vs Rectal Cancer Lessons from Hohenberger
🔹 Rationale: Avoid spillage, enhance lymphadenectomy
🔹 Mobilization Matters
📌 Bokey etal: Anatomical plane-based dissection
📌 West et al:Better planes = Improved survival(1/2)
🚀 Innovations to Avoid Double Stapling (DS) in Rectal Anastomosis by @AntoninoSpin
🔹 DS is widely used but has drawbacks: dog ears, non-uniform anastomosis & higher leak rates.
🔹 FDA: DS is suboptimal.
🔹 Simplified stapling for rectosigmoid/upper rectal tumors.
(1/3)
HIPEC in CRC by @DeliaCortesGuir
Key Insights
🔬 HIPEC in CRC - controversial
📈 Netherlands trial & Cashin et al → 🔥 survival benefit
❌ PRODIGE 7 → 🚫 no benefit
❌ COLOPEC, PROPHYLOCHIP 🚫 no benefit with oxaliplatin
(1/3)
Outcomes in Robotic-assisted Compared to Laparoscopic-assisted Colorectal Surgery in Newly Established Colorectal Tertiary Center: Our Experience and Challenges Faced: https://t.co/znuqjiKHni
COLLISION trial 🇳🇱 just out @TheLancetOncol
1st RCT: Ablation vs surgery for small (<3cm, <10 mets) colorectal liver mets
☑️Overall survival similar
☑️Slightly better local control per tumor in ablation group!
☑️Less adverse events in ablation group
https://t.co/GMTxAVPfzz
This study suggests using an early warning score of 2.4 and a CRP level of 180 mg/L on postoperative day 3 following colon surgery with anastomosis as threshold values to prompt investigation and treatment of AL. https://t.co/j8uclp4Kmg
Happy New Year from the Emoroid Digest ! 🎆
Check out this visual summary of the AGA Clinical Practice Update on Management of Ostomies by Dr. Ikenna Kingsley Emelogu
@AmerGastroAssn
🎉Happy New Year! Excited to share our guide on robotic TME
@TechColoproctol, outlining key tractions for each step. https://t.co/EaZnpd4VFl
Thank you to unique mentors:
@JGMAzevedo,@LauraFz_MD, Prof @AntoninoSpin
and Prof. Amjad Parvaiz!
My 🌂 review concluded that "However, the lack of robust data from well-designed multicenter randomized trials may prevent drawing firm conclusions on the oncologic benefits of CME".
Glad to see robust evidence to complete the conclusion. @ZGaroufalia https://t.co/YVS5Eez48y
The #RELARC trial was highly-anticipated, but scarcely-discussed online when it was published this Fall.
This was a massive effort from 17 hospitals in China that randomized >1000 patients with right-sided colon cancer to either CME or the more-traditional D2 dissection.
They found no benefit to CME in terms of 3-year DFS or OS.
I would love to hear the thoughts of both pro-CME and anti-CME surgeons.
Also, happy holidays to everyone!
https://t.co/NPhzh7LvFO
Bowel preparation before elective right colectomy: Multitreatment machine-learning analysis on 2,617 patients https://t.co/PV9EnX7WAt @SurgJournal “…. mechanical bowel preparation with oral antibiotics is associated with a decrease in surgical-site infections after elective right colectomy compared with no bowel preparation.”